Assignee
SPLASH PHARMACEUTICALS INC
US·0 granted patents·6 pending applications·0 citations·filing 2017–2023
Top patents by PatentIndex Score
6 records- 0166US2024050515A1Methods and compositions for treating cd44+ cancersSPLASH PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0263US2023183290A1Methods for treating cancer using spl-108 polypeptide based on tp53 mutational statusSPLASH PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0363US2023272103A1Cd44-modulating compositions for methods for treating cancers and ascitesSPLASH PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0452US2020299355A1Methods for diagnosing and treating diseases based on modulating drug efflux by binding to cryptic region of cd44SPLASH PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0552US2022125893A1Methods for treating arthritis using spl-108 peptideSPLASH PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0640US2019381127A1Combination therapy with a6, chemotherapeutic agents, radiation therapy, or a combination thereof for the treatment of cancerSPLASH PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →